Marine-derived n-3 fatty acids therapy for stroke

Celia Gabriela Alvarez Campano*, Mary Joan Macleod, Frank Thies, Lorna Aucott, Malcolm R. Macleod

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)
10 Downloads (Pure)


This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of marine-derived n-3 fatty acids administration on functional outcomes and dependence in people with stroke.

Original languageEnglish
Article numberCD012815
Pages (from-to)1-12
Number of pages12
JournalCochrane Database of Systematic Reviews
Issue number10
Publication statusPublished - 10 Oct 2017

Bibliographical note

We thank the Cochrane Stroke Group, and in particular Hazel Fraser (Managing Editor) and Joshua Cheyne (Trials Search Coordinator and Information Specialist), for their support in the development of this protocol.

CG Alvarez Campano is funded by the Mexican Council for Science and Technology (CONACyT) and the Institute of Innovation and Technology Transfer (I²T²) (grant number 457349).


Dive into the research topics of 'Marine-derived n-3 fatty acids therapy for stroke'. Together they form a unique fingerprint.

Cite this